Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs
— December 24, 2018Europeans have found the secret to making some of the world’s costliest medicines much more affordable, as much as 80 percent cheaper than in the U.S. Governments in Europe have compelled drugmakers to bend on prices and have thrown open the market for so-called biosimilars, which are cheaper copies of biologic drugs made from living […]
Continue Reading ...